Menu
Home
Company
About Us
People
Network
Careers
Sustainability
Compliance
FAQ
Portfolio
Portfolio
Technology
Products
InVue
InForm
InVivage
ViewnVivo
InSpecta
Pipeline
Publications
Image Gallery
Webinars
FAQ
Investor
Investor Overview
ASX Announcements
Financial Reports
Share Price Information
Investor Relations
Investor Alerts
Entitlement Prospectus
News
News
Blog
Events
Contact
Contact
Select Category
Clinical Research
Oral cancer diagnosis and surgical margin
Brain cancer
General surgery
Cervical assessment
Gastrointestinal assessment
Life Sciences Research
Cell viability
Live antibody labelling
Intraoperative surgery and tumour margin delineation
Blood vessel, perfusion, and barrier function
Live microflora imaging
Nano particle and drug delivery
Proof of concept in live models
Recent Posts
Optiscan in the news - Optiscan Imaging Ltd Launches US Breast Cancer Imaging Study With Mayo Clinic
Optiscan in the news - Optiscan to start new US breast cancer imaging study
Optiscan in the news - Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule
Optiscan in the news - Health Check: No ‘burnt toast’ excuses as Optiscan trial runs ahead of schedule
Optiscan in the news - The Future of Pathology: Real-Time Imaging at the Point of Care
Archives
July 2026
June 2026
May 2026
April 2026
March 2026
February 2026
January 2026
December 2025
November 2025
October 2025
August 2025
July 2025
June 2025
May 2025
April 2025
March 2025
February 2025
January 2025
December 2024
November 2024
October 2024
September 2024
August 2024
July 2024
June 2024
May 2024
April 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
November 2022
Categories
Announcements
Blogs
Blood vessel, perfusion, and barrier function
Brain cancer
Broker Research
Cell viability
Cervical assessment
Gastrointestinal assessment
General surgery
Intraoperative surgery and tumour margin delineation
Live antibody labelling
Live microflora imaging
Nano particle and drug delivery
Optiscan news
Oral cancer diagnosis and surgical margin
Proof of concept in live models
Uncategorized
Veterinary
Optiscan in the news - Optiscan Imaging Ltd Launches US Breast Cancer Imaging Study With Mayo Clinic
22-Jul-2026 by Leah Sneddon
Read More
Optiscan in the news - Optiscan to start new US breast cancer imaging study
22-Jul-2026 by Leah Sneddon
Read More
Optiscan in the news - Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule
21-Jul-2026 by Leah Sneddon
Read More
Optiscan in the news - Health Check: No ‘burnt toast’ excuses as Optiscan trial runs ahead of schedule
21-Jul-2026 by Leah Sneddon
Read More
Optiscan in the news - The Future of Pathology: Real-Time Imaging at the Point of Care
10-Jul-2026 by Leah Sneddon
Read More
Optiscan in the news - InSpecta launches in the US vet market (Long Shortz)
09-Jul-2026 by Leah Sneddon
Read More
Optiscan in the news - Optiscan launches InSpecta device in US veterinary market
07-Jul-2026 by Leah Sneddon
Read More
Optiscan in the news - The Australian business disrupting global healthcare [2GB interview]
01-Jul-2026 by Leah Sneddon
Read More
1
Back to All Publications
